US Stock MarketDetailed Quotes

LNTH Lantheus

Watchlist
  • 98.430
  • -1.340-1.34%
Close Mar 26 16:00 ET
  • 98.980
  • +0.550+0.56%
Post 20:01 ET
6.75BMarket Cap22.58P/E (TTM)

About Lantheus Company

Lantheus Holdings, Inc. engages in the provision of diagnostic imaging and nuclear medicine products. The firm develops products that help healthcare professionals in patient management and outcomes and assists clinicians with the detection of cardiovascular disease. It operates through the U.S. and International geographical segments. The U.S. segment produces and markets products, radiopharmacies, PMFs, integrated delivery networks, hospitals, clinics, and group practices throughout the United States. The International segment offers direct distribution in Canada and third-party distribution relationships in Europe, Canada, Australia, Asia-Pacific, Central America, and South America. The company was founded in 1956 and is headquartered in Bedford, MA.

Company Profile

SymbolLNTH
Company NameLantheus
Listing DateJun 25, 2015
Issue Price6.00
Founded1956
CEOMr. Brian A. Markison
MarketNASDAQ
Employees808
Fiscal Year Ends12-31
Address201 Burlington Road,South Building
CityBedford
ProvinceMassachusetts
CountryUnited States of America
Zip Code01730
Phone1-978-671-8001

Company Executives

  • Name
  • Position
  • Salary
  • Brian A. Markison
  • Director and Chief Executive Officer
  • 13.40M
  • Daniel M. Niedzwiecki
  • Chief Administrative Officer, General Counsel and Corporate Secretary
  • 4.35M
  • Jamie Spaeth
  • Chief People Officer
  • --
  • Robert J. Marshall, Jr
  • Chief Financial Officer and Treasurer
  • 5.43M
  • Amanda Morgan
  • Chief Commercial Officer
  • 2.81M
  • Dr. Jean-Claude Provost
  • Chief Science Officer
  • 3.49M
  • Kimberly Brown
  • Chief Accounting Officer
  • --
  • Paul M. Blanchfield
  • President of the Company and Its Subsidiaries
  • 5.31M
  • Minnie V. Baylor-Henry
  • Independent Director
  • 483.41K
  • Julie H. McHugh
  • Lead Independent Director
  • 483.41K
  • Dr. James H. Thrall
  • Independent Director
  • 490.91K
  • Heinz Mausli
  • Independent Director
  • 482.16K
  • Dr. Phuong Khanh Morrow, F.A.C.P.
  • Independent Director
  • --
  • Dr. Gerard Ber, PhD
  • Independent Director
  • 475.91K
  • Samuel R. Leno
  • Independent Director
  • 494.66K
  • Julie M. Eastland
  • Independent Director
  • 284.68K
  • Gary John Pruden
  • Independent Director
  • 494.66K
  • Mary Anne Heino
  • Chairperson of the Board
  • 787.60K
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.